rs777882844
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018139.3(DNAAF2):āc.2191G>Cā(p.Glu731Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,612,258 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_018139.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAAF2 | NM_018139.3 | c.2191G>C | p.Glu731Gln | missense_variant | 3/3 | ENST00000298292.13 | NP_060609.2 | |
DNAAF2 | NM_001083908.2 | c.2047G>C | p.Glu683Gln | missense_variant | 2/2 | NP_001077377.1 | ||
DNAAF2 | NM_001378453.1 | c.-21G>C | 5_prime_UTR_variant | 2/2 | NP_001365382.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAAF2 | ENST00000298292.13 | c.2191G>C | p.Glu731Gln | missense_variant | 3/3 | 1 | NM_018139.3 | ENSP00000298292.8 | ||
DNAAF2 | ENST00000406043.3 | c.2047G>C | p.Glu683Gln | missense_variant | 2/2 | 1 | ENSP00000384862.3 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152122Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249298Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134674
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1460136Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 726228
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152122Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74306
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 731 of the DNAAF2 protein (p.Glu731Gln). This variant is present in population databases (rs777882844, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with DNAAF2-related conditions. ClinVar contains an entry for this variant (Variation ID: 411171). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2021 | The p.E731Q variant (also known as c.2191G>C), located in coding exon 3 of the DNAAF2 gene, results from a G to C substitution at nucleotide position 2191. The glutamic acid at codon 731 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at